Detalhe da pesquisa
1.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 25(5): 572-587, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38561010
2.
Oral HPV16 DNA as a screening tool to detect early oropharyngeal squamous cell carcinoma.
Cancer Sci
; 111(10): 3854-3861, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32713038
3.
Helical intensity-modulated radiotherapy with concurrent chemotherapy for oropharyngeal squamous cell carcinoma: A prospective investigation of acute swallowing and toxicity patterns.
Head Neck
; 40(9): 1955-1966, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29756244